ArticleAssay and drug development technologies2015

High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes.

Fabian Alexander Grimm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.